6-amino-1-hydroxyhexane-1,1-diphosphonate and Multiple Myeloma

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Multiple Myeloma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baroni, MC; Costi, D; Mangoni, M; Maulucci, L; Pittari, G; Raballo, M	1

Other Studies

1 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Multiple Myeloma

Article	Year
Intravenous neridronate for skeletal damage treatment in patients with multiple myeloma. Acta bio-medica : Atenei Parmensis, 2006, Volume: 77, Issue:2 Topics: Aged; Alkaline Phosphatase; Bone Density; Bone Resorption; Calcium; Diphosphonates; Female; Hip; Humans; Infusions, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Multiple Myeloma; Osteoclasts; Osteolysis; Safety; Time Factors; Treatment Outcome	2006

Article

Year

Intravenous neridronate for skeletal damage treatment in patients with multiple myeloma.

Acta bio-medica : Atenei Parmensis, 2006, Volume: 77, Issue:2

Topics: Aged; Alkaline Phosphatase; Bone Density; Bone Resorption; Calcium; Diphosphonates; Female; Hip; Humans; Infusions, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Multiple Myeloma; Osteoclasts; Osteolysis; Safety; Time Factors; Treatment Outcome

2006